메뉴 건너뛰기




Volumn 11, Issue 5-6, 2004, Pages 253-258

Differential toxicity of antracyclines on cultured endothelial cells

Author keywords

Doxil; Doxorubicin; Endothelial cells; Mcl 1; p53

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CASPASE 3; DAUNORUBICIN; DNA FRAGMENT; DOXORUBICIN; IDARUBICIN; LIPOSOME; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN MCL 1; ANTHRACYCLINE; CASP3 PROTEIN, HUMAN; CASPASE; PROTEIN P53;

EID: 12344272684     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320490904124     Document Type: Article
Times cited : (26)

References (25)
  • 1
    • 0032575688 scopus 로고    scopus 로고
    • The Bcl-2 protein family: Arbiters of cell survival
    • Adams J.M., and Cory S. (1998) The Bcl-2 protein family: Arbiters of cell survival. Science, 281, 1322-1326.
    • (1998) Science , vol.281 , pp. 1322-1326
    • Adams, J.M.1    Cory, S.2
  • 3
    • 0030713362 scopus 로고    scopus 로고
    • Anthracyclines in the treatment of cancer. An overview
    • Hortobagyi G.N. (1997) Anthracyclines in the treatment of cancer. An overview. Drugs, 54(Suppl 4), 1-7.
    • (1997) Drugs , vol.54 , Issue.SUPPL. 4 , pp. 1-7
    • Hortobagyi, G.N.1
  • 5
    • 0031950286 scopus 로고    scopus 로고
    • Anthracyclines in haematology: Pharmacokinetics and clinical studies
    • Johnson S.A., and Richardson D.S. (1998) Anthracyclines in haematology: Pharmacokinetics and clinical studies. Blood Reviews, 12, 52-71.
    • (1998) Blood Reviews , vol.12 , pp. 52-71
    • Johnson, S.A.1    Richardson, D.S.2
  • 6
    • 0034778721 scopus 로고    scopus 로고
    • Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells
    • Kaushal G.P., Kaushal V., Hong X., and Shah SN. (2001) Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney International, 60, 1726-1736.
    • (2001) Kidney International , vol.60 , pp. 1726-1736
    • Kaushal, G.P.1    Kaushal, V.2    Hong, X.3    Shah, S.N.4
  • 7
    • 4644316831 scopus 로고    scopus 로고
    • Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology
    • Kaushal V., Kaushal G.P., Melkaveri S.N., and Mehta P. (2004) Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology. Joural of Thrombosis and Haemostay, 2, 327-334.
    • (2004) Journal of Thrombosis and Haemostay , vol.2 , pp. 327-334
    • Kaushal, V.1    Kaushal, G.P.2    Melkaveri, S.N.3    Mehta, P.4
  • 8
    • 0034721770 scopus 로고    scopus 로고
    • Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species
    • Kotamraju S., Konorev E.A., Joseph J., and Kalyanaraman B. (2000) Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. Journal of Biological Chemistry 275, 33585-33592.
    • (2000) Journal of Biological Chemistry , vol.275 , pp. 33585-33592
    • Kotamraju, S.1    Konorev, E.A.2    Joseph, J.3    Kalyanaraman, B.4
  • 10
    • 0034523687 scopus 로고    scopus 로고
    • The cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity
    • Kwok J.C., and Richardson D.R. (2000) The cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity. Redox Report, 5, 317-324.
    • (2000) Redox Report , vol.5 , pp. 317-324
    • Kwok, J.C.1    Richardson, D.R.2
  • 12
    • 0025051505 scopus 로고
    • Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses
    • Olson R.D., and Mushlin P.S. (1990) Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses. FASEB Journal, 4, 3076-3086.
    • (1990) FASEB Journal , vol.4 , pp. 3076-3086
    • Olson, R.D.1    Mushlin, P.S.2
  • 13
    • 0141786833 scopus 로고    scopus 로고
    • Cardiac safety of liposomal anthracyclines
    • Safra T. (2003) Cardiac safety of liposomal anthracyclines. Oncologist, 8 (Suppl 2), 17-24.
    • (2003) Oncologist , vol.8 , Issue.SUPPL. 2 , pp. 17-24
    • Safra, T.1
  • 14
    • 0033113566 scopus 로고    scopus 로고
    • Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer
    • The Provincial Systemic Treatment Disease Site Group
    • Seymour L., Bramwell V., and Moran L.A. (1999) Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group. Cancer Prevention and Control 3, 145-159.
    • (1999) Cancer Prevention and Control , vol.3 , pp. 145-159
    • Seymour, L.1    Bramwell, V.2    Moran, L.A.3
  • 15
    • 0031722185 scopus 로고    scopus 로고
    • Strategies for reduction of anthracycline cardiac toxicity
    • Speyer J., and Wasserheit C. (1998) Strategies for reduction of anthracycline cardiac toxicity. Seminars in Oncology, 25, 525-537.
    • (1998) Seminars in Oncology , vol.25 , pp. 525-537
    • Speyer, J.1    Wasserheit, C.2
  • 17
    • 0141842640 scopus 로고    scopus 로고
    • Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity
    • Swift L., McHowat J., and Sarvazyan N. (2003) Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity. Cancer Research, 63, 5992-5998.
    • (2003) Cancer Research , vol.63 , pp. 5992-5998
    • Swift, L.1    McHowat, J.2    Sarvazyan, N.3
  • 18
    • 2342488025 scopus 로고    scopus 로고
    • Cardiac profiles of liposomal anthracyclines
    • Theodoulou M., and Hudis C. (2004) Cardiac profiles of liposomal anthracyclines. Cancer, 100, 2052-2063.
    • (2004) Cancer , vol.100 , pp. 2052-2063
    • Theodoulou, M.1    Hudis, C.2
  • 19
  • 20
    • 2942616456 scopus 로고    scopus 로고
    • Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H(2)O(2)- and p53-dependent pathways
    • Wang S., Konorev E.A., Kotamraju S., Joseph J., Kalivendi S., and Kalyanaraman, B. (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H(2)O(2)- and p53-dependent pathways. Journal of Biological Chemistry 279, 25535-25543.
    • (2004) Journal of Biological Chemistry , vol.279 , pp. 25535-25543
    • Wang, S.1    Konorev, E.A.2    Kotamraju, S.3    Joseph, J.4    Kalivendi, S.5    Kalyanaraman, B.6
  • 21
    • 0026714331 scopus 로고
    • The anthracyclines: Will we ever find a better doxorubicin?
    • Weiss R.B. (1992) The anthracyclines: Will we ever find a better doxorubicin? Seminars in Oncology, 19, 670-686.
    • (1992) Seminars in Oncology , vol.19 , pp. 670-686
    • Weiss, R.B.1
  • 22
    • 0034063979 scopus 로고    scopus 로고
    • Anthracycline-induced cardiotoxicity: Clinical course, risk factors, pathogenesis, detection and prevention - Review of the literature
    • Wojtacki J., Lewicka-Nowak E., and Lesniewski-Kmak K. (2000) Anthracycline-induced cardiotoxicity: Clinical course, risk factors, pathogenesis, detection and prevention - review of the literature. Medical Science Monitor 6, 411-420.
    • (2000) Medical Science Monitor , vol.6 , pp. 411-420
    • Wojtacki, J.1    Lewicka-Nowak, E.2    Lesniewski-Kmak, K.3
  • 23
    • 0032724653 scopus 로고    scopus 로고
    • Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation
    • Wolf B.B., Schuler M., Echeverri F., and Green D.R. (1999) Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. Journal of Biological Chemistry, 274, 30651-30656.
    • (1999) Journal of Biological Chemistry , vol.274 , pp. 30651-30656
    • Wolf, B.B.1    Schuler, M.2    Echeverri, F.3    Green, D.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.